AstraZeneca plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZN New York 2834 https://www.astrazeneca.com/Home

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca plc (ADR)

A Look at Shire’s Valuation on September 19 - Sep 20th, 2018 1:22 pm
Merck or Pfizer: Which is the Better Large-Cap Pharma Stock? - Sep 20th, 2018 8:54 am
FOCUS-AstraZeneca plots China robot offensive to counter price cuts - Sep 19th, 2018 5:00 pm
AstraZeneca's Fasenra Long-Term Asthma Study Data Positive - Sep 19th, 2018 8:46 am
Focus: AstraZeneca plots China robot offensive to counter price cuts - Sep 19th, 2018 1:02 am
AstraZeneca plots China robot offensive to counter price cuts - Sep 18th, 2018 11:08 pm
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? - Sep 18th, 2018 6:13 am
FASENRA (benralizumab) Shows Consistent Safety and Sustained Efficacy in Long-Term Phase III BORA Trial in Severe Eosinophilic Asthma - Sep 18th, 2018 5:00 am
AstraZeneca-Backed ADC Therapeutics Weighs IPO, Sale - Sep 17th, 2018 10:06 am
Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus - Sep 14th, 2018 8:02 am
AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia - Sep 14th, 2018 7:27 am
Johnson & Johnson Expands Blood Cancer Portfolio with Approval - Sep 14th, 2018 5:31 am
US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia - Sep 13th, 2018 2:14 pm
FDA approves AstraZeneca's drug for rare form of blood cancer - Sep 13th, 2018 12:34 pm
Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study - Sep 13th, 2018 7:13 am
3 Lung Cancer Stocks That Could End September on a High Note - Sep 13th, 2018 6:45 am
The Outlook for AstraZeneca Is Positive, But It’s Too Early to Pull the Trigger - Sep 12th, 2018 9:25 am
Immunotherapy for NSCLC: 4 Large-Cap Pharma Stocks in Focus - Sep 12th, 2018 7:45 am
The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson - Sep 10th, 2018 6:04 am
Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus - Sep 7th, 2018 8:41 am